2 news items
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
AGRX
15 May 24
performance. We define the term non-GAAP net loss as GAAP net loss excluding recurring unrealized gains or losses pertaining to liability classified
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
AGRX
28 Mar 24
unrealized gains or losses pertaining to liability classified warrants and one-time non-cash charges incurred in connection with the loss on disposition
- Prev
- 1
- Next